173 results on '"Gierth, Michael"'
Search Results
2. Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer—21-yr Follow-up
3. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node–Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score–Weighted Competing Risks Analysis
4. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort
5. The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians
6. Risk factors for bladder neck contracture after transurethral resection of the prostate
7. Metabolic Alkalosis
8. Short-Term and Long-Term Morbidity after Radical Cystectomy in Patients with NMIBC and Comparison with MIBC: Identifying Risk Factors for Severe Short-Term Complications
9. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy
10. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011
11. Epithelial–mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma
12. Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study
13. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort
14. Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the Bladder
15. Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta
16. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder
17. Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer
18. Evidence from the ‘PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)’ Study: How are Preoperative Patient Characteristics Associated with Urinary Diversion Type After Radical Cystectomy for Bladder Cancer?
19. A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14
20. EXTRACAPSULAR EXTENSION AND LYMPH NODE DENSITY IN UROTHELIAL CARCINOMA OF THE BLADDER FOLLOWING RADICAL CYSTECTOMY IN NODAL-POSITIVE PATIENTS: MP38-15
21. HOSPITAL BUT NOT SURGICAL VOLUME PREDICTS 30- AND 90-DAY COMPLICATIONS IN RADICAL CYSTECTOMY (RC) – RESULTS FROM THE PROSPECTIVE MULTICENTER RADICAL CYSTECTOMY SERIES (PROMETRICS 2011) STUDY GROUP: PD02-04
22. MP58-16 PREDICTION OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RADICAL CYSTECTOMY FOR BLADDER CANCER USING ARTIFICIAL NEURAL NETWORKS
23. Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
24. Editorial Comment to Obese patients undergoing cystectomy: A population-based, propensity score matched analysis
25. DO PREOPERATIVE PATIENT CHARACTERISTICS INFLUENCE URINARY DIVERSION AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER? – RESULTS OF THE GERMAN PROMETRICS 2011 STUDY: MP61-12
26. The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer
27. Prognostic Role of mRNA-Expression of Aquaporins (AQP) 3, 4, 7 and 9 in Stage pT1 Non-Muscle-Invasive Bladder Cancer
28. BLADDER CANCER: Progress in defining progression in NMIBC
29. Epidemiology and therapy of symptomatic lymphoceles after robot-assisted radical prostatectomy (RARP)
30. Eisenstatuserhebung vor radikaler Zystektomie beim Urothelkarzinom der Harnblase
31. Die Komplikationen der radikalen Zystektomie mit Harnableitung: Eine retrospektive, monozentrische Studie
32. Results of a phase I/II single arm clinical trial assessing efficacy, safety and tolerability of the recombinant Bacillus Calmette Guérin VPM1002BC in patients with non-muscle invasive bladder cancer recurrence after BCG induction with or without BCG maintenance therapy – SAKK 06/14
33. Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer
34. Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer
35. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer
36. Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study
37. Klinische und pathologische Prognosefaktoren für das Langzeitüberleben von Patienten mit pT1 Nierenzellkarzinom
38. PD36-08 PERIOPERATIVE ALLOGENEIC BLOOD TRANSFUSION DOES NOT ADVERSELY IMPACT SURVIVAL AFTER RADICAL CYSTECTOMY FOR URINARY BLADDER CANCER - A COMPETING-RISKS ANALYSIS FROM A MULTI-INSTITUTIONAL EUROPEAN SERIES
39. PD02-04 HOSPITAL BUT NOT SURGICAL VOLUME PREDICTS 30- AND 90-DAY COMPLICATIONS IN RADICAL CYSTECTOMY (RC) – RESULTS FROM THE PROSPECTIVE MULTICENTER RADICAL CYSTECTOMY SERIES (PROMETRICS 2011) STUDY GROUP
40. MP38-15 EXTRACAPSULAR EXTENSION AND LYMPH NODE DENSITY IN UROTHELIAL CARCINOMA OF THE BLADDER FOLLOWING RADICAL CYSTECTOMY IN NODAL-POSITIVE PATIENTS
41. Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder Cancer.
42. Virtual Mold Sampling for Robust Processes
43. Epithelial–mesenchymal transformation markers E-cadherin and survivin predict progression of stage pTa urothelial bladder carcinoma
44. Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy - A Prospective Multicenter Study
45. Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer
46. Antiplatelet and Anticoagulative Medication During Shockwave Lithotripsy
47. Comparative Analysis of Gender-Related Differences in Symptoms and Referral Patterns prior to Initial Diagnosis of Urothelial Carcinoma of the Bladder: A Prospective Cohort Study
48. Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
49. MP61-12 DO PREOPERATIVE PATIENT CHARACTERISTICS INFLUENCE URINARY DIVERSION AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER? – RESULTS OF THE GERMAN PROMETRICS 2011 STUDY
50. The Charlson Comorbidity Index Predicts Survival after Disease Recurrence in Patients following Radical Cystectomy for Urothelial Carcinoma of the Bladder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.